Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’Karin P.S. Langenberg, Patrick Kemmeren, Michael T. Meister et al.|European Journal of Cancer|2022Cited by 61
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Aurora Castellano, Geneviève Laureys et al.|Journal of Clinical Oncology|2024Cited by 25
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II TrialJuliet C. Gray, Lucas Moreno, Rebekah Weston et al.|Journal of Clinical Oncology|2025Cited by 8
Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case ReportCaroline C. C. Hulsker, Leendert H. J. Looijenga, Mariëtte E.G. Kranendonk et al.|International Journal of Molecular Sciences|2021Cited by 1
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325]Karin P.S. Langenberg, Patrick Kemmeren, Michael T. Meister et al.|European Journal of Cancer|2025Cited by 1